DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Wednesday reported a loss of $2.4 million in its first quarter.
On a per-share basis, the Dublin, Ohio-based company said it had a loss of 24 cents.
The biopharmaceutical posted revenue of $136,000 in the period.
In the final minutes of trading on Wednesday, the company's shares hit $2.26. A year ago, they were trading at $5.30.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NAVB at https://www.zacks.com/ap/NAVB